TopFIND 4.0

P47809: Dual specificity mitogen-activated protein kinase kinase 4

General Information

Protein names
- Dual specificity mitogen-activated protein kinase kinase 4
- MAP kinase kinase 4
- MAPKK 4
- 2.7.12.2
- C-JUN N-terminal kinase kinase 1
- JNK kinase 1
- JNKK 1
- JNK-activating kinase 1
- MAPK/ERK kinase 4
- MEK 4
- SAPK/ERK kinase 1
- SEK1

Gene names Map2k4
Organism Mus musculus
Protease Family
Protease ID
Chromosome location
UniProt ID P47809

3

N-termini

2

C-termini

0

Cleavages

0

Substrates

Sequence

        10         20         30         40         50         60 
MAAPSPSGGG GSGGGGGTPG PIGPPASGHP AVSSMQGKRK ALKLNFANPP VKSTARFTLN 
        70         80         90        100        110        120 
PNTTGVQNPH IERLRTHSIE SSGKLKISPE QHWDFTAEDL KDLGEIGRGA YGSVNKMVHK 
       130        140        150        160        170        180 
PSGQIMAVKR IRSTVDEKEQ KQLLMDLDVV MRSSDCPYIV QFYGALFREG DCWICMELMS 
       190        200        210        220        230        240 
TSFDKFYKYV YSVLDDVIPE EILGKITLAT VKALNHLKEN LKIIHRDIKP SNILLDRSGN 
       250        260        270        280        290        300 
IKLCDFGISG QLVDSIAKTR DAGCRPYMAP ERIDPSASRQ GYDVRSDVWS LGITLYELAT 
       310        320        330        340        350        360 
GRFPYPKWNS VFDQLTQVVK GDPPQLSNSE EREFSPSFIN FVNLCLTKDE SKRPKYKELL 
       370        380        390    
KHPFILMYEE RTVEVACYVC KILDQMPATP SSPMYVD

Isoforms



Sequence View



Filter Information:


(REFRESH)

Directness:


Physiological Relevance:


Evidence Codes:


Methodology:


Perturbation of System:


Biological System:


Protease Assignment Confidence:


Evidence Names:


Database:


Lab:



Protein Neighborhood

Domains & Features

3 N-termini - 2 C-termini - 0 Cleavages - 0 Substrates

N-termini

C-termini

Cleavages

    Protease Position Sequence Evidence type Method Source (database) Source (Lab) Evidence name Publications (PMIDs)

Substrates

    Substrate Position Sequence Evidence type Method Source (database) Source (Lab) Evidence name Publications (PMIDs)